Key Takeaways:
- The Digital Therapeutics Alliance (DTA) and Healthware Group launch the first DTx Policy Report and dedicated website.
- The report focuses on policy frameworks for digital therapeutics (DTx) in Europe.
- The website provides resources and best practices for integrating DTx into healthcare systems.
The Digital Therapeutics Alliance (DTA) and Healthware Group have collaborated to launch the first DTx Policy Report and a dedicated website. The aim is to advance equitable access and adoption of safe and effective Digital Therapeutics (DTx) and Digital Medical Devices (DMD). Presented at the DTA Summit 2023 press conference in Washington DC, the inaugural report titled “DTx Policy Pathways: the evolving scenario in Europe; Landscape Analysis & Converging Trends” marks a significant milestone for the European DTx Policy Coalition.
Advancing Policy Frameworks for DTx
Through the European DTx Policy Coalition, the DTA and Healthware Group, as the official knowledge partner, have actively engaged with stakeholders, including Ministries of Health, national trade associations, and European trade associations. Their collaborative efforts focus on establishing comprehensive best practice frameworks for the utilization of digital medical devices, including digital therapeutics.
The report highlights the increasing number of European countries that have developed or are developing appraisal criteria, access, and reimbursement policies for DTx and the broader DMD category. However, despite progress, there is a patchwork of nomenclatures and approaches being applied. While some countries have successfully provided equitable access and fostered systemic uptake of clinically-validated DMDs, others lack fit-for-purpose frameworks, hindering timely access to these therapies.
Clarity and Convergence in Policy Frameworks
To address this challenge, the initial DTx Policy Report provides clarity on existing and evolving policy frameworks in Europe. It delves into the appraisal criteria being applied in countries with formal frameworks in place, analyzing requirements through the common lens of the Health Technology Assessment (HTA) Core Model®. Additionally, the report identifies converging trends that can inform areas of potential harmonization and scalability across Europe and globally.
A Dedicated Resource: The DTx Policy Landscape Website
In conjunction with the report, the newly launched website, https://dtxpolicylandscape.org, offers valuable tools and resources. The platform is designed to promote best practices in integrating DTx into healthcare systems. Its aim is to empower clinicians, decision-makers, and policymakers to recognize the value of DTx and include them within regional and national frameworks. By providing these resources, the website aims to drive equitable digital healthcare for patients on a global scale.
Megan Coder, Chief Policy Officer & Founder of Digital Therapeutics Alliance, expresses the privilege of working with policymakers and payors worldwide to ensure equitable patient access to digital therapies. She emphasizes the comprehensive set of resources developed during the first phase of the Coalition, enabling greater clarity and harmonization in how digital therapeutics are evaluated and implemented. Coder believes that moving closer to a globally recognized framework for digital therapies will provide patients and caregivers with new opportunities to optimize their healthcare experiences.
Alberta Spreafico, Managing Director Digital Health & Innovation at Healthware Group, highlights the importance of enabling equitable and sustainable access to DTx. She stresses the need for defining fit-for-purpose appraisal criteria and establishing adequate access and reimbursement policies. Spreafico expresses pride in joining forces with the Digital Therapeutics Alliance as a knowledge partner. The collaboration aims to support all ecosystem stakeholders through in-depth knowledge, continuous monitoring of the evolving scenario, and the curation of valuable resources on https://dtxpolicylandscape.org. This collaborative effort will help scale the systemic integration and impact of DTx.
Roberto Ascione, CEO at Healthware Group, expresses his pride in the collaborative work done with the DTA. He notes that the development of this valuable resource aligns with Healthware’s vision of Future Health. Ascione emphasizes Healthware’s commitment to assisting life science companies in communicating, connecting, and building innovative solutions that enable better healthcare. He believes that the DTx Policy Report is a significant contribution to support the adoption and access of DTx globally.
Joining the Effort for Equitable Digital Healthcare
The launch of the DTx Policy Report and website represents a major step forward in promoting equitable access and adoption of digital therapeutics. By providing clarity on policy frameworks and offering valuable resources, the DTA and Healthware Group aim to empower stakeholders and drive systemic integration of DTx into healthcare systems. With a globally recognized framework, patients and caregivers can benefit from optimized healthcare experiences. Visit https://dtxpolicylandscape.org for more information and to download the report.
Sign up to our newsletter & get the most important monthly insights from around the world.
Ready to Amplify Your Brand with Business Today?
Discover the power of sponsored articles and partnerships to reach decision-makers, professionals, and a dynamic audience. Learn more about our advertising opportunities and connect with us today!
Click here to explore our Promotion & Sponsored Articles page.
Are you looking to make an impact? Contact us at [email protected] to get started!
